Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

A Study Comparing 4 Dose Regimens of PLA-695, Naproxen, and Placebo In Subjects With Osteoarthritis Of The Knee

ClinicalTrials.gov ID: NCT00396955

Public ClinicalTrials.gov record NCT00396955. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 1:31 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind Comparison of 4 Dose Regimens of Pla-695, Naproxen, and Placebo Administered Daily for 6 Weeks in Subjects With Active Osteoarthritis of the Knee

Study identification

NCT ID
NCT00396955
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Industry
Enrollment
560 participants

Conditions and interventions

Conditions

Interventions

  • PLA-695 Drug

Drug

Eligibility (public fields only)

Age range
50 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2006
Primary completion
Oct 31, 2007
Completion
Oct 31, 2007
Last update posted
Dec 27, 2007

2006 – 2007

United States locations

U.S. sites
39
U.S. states
21
U.S. cities
37
Facility City State ZIP Site status
Not listed Huntsville Alabama 35801
Not listed Scottsdale Arizona 85251
Not listed Tucson Arizona 85704
Not listed Tucson Arizona
Not listed Palo Alto California 94304
Not listed Rancho Mirage California 92270
Not listed Santa Maria California 93455
Not listed Upland California 91786
Not listed Delray Beach Florida 33484
Not listed Fort Lauderdale Florida 33334
Not listed Ocala Florida 34474
Not listed Palm Harbor Florida 34684
Not listed South Miami Florida 33143
Not listed Tampa Florida 33614
Not listed Idaho Falls Idaho 83401
Not listed Chicago Illinois 60611
Not listed Wichita Kansas 67208
Not listed Baltimore Maryland 21224
Not listed Frederick Maryland 21702
Not listed Fall River Massachusetts 02720
Not listed Kalamazoo Michigan 49048
Not listed St Louis Missouri 63128
Not listed Las Vegas Nevada
Not listed Dover New Hampshire 03820
Not listed Mamaroneck New York 10543
Not listed Syracuse New York 13210
Not listed Charlotte North Carolina 28210
Not listed Duncansville Pennsylvania 16635
Not listed West Reading Pennsylvania 19611
Not listed Willow Grove Pennsylvania 19090
Not listed Charleston South Carolina 29406
Not listed Dallas Texas 75231
Not listed Dallas Texas 75235
Not listed San Antonio Texas 78217
Not listed Salt Lake City Utah 84107
Not listed Seattle Washington 98166
Not listed Spokane Washington 99204
Not listed Tacoma Washington 98405
Not listed Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 44 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00396955, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 27, 2007 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00396955 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →